CDK4 and breast cancer: More importantly, we found for the first time that circACTN4 is capable of augmenting the expression levels of CCNE1 and CDK4 by enhancing the AcH4 level of these genes induced by MYC, thus promoting the progression of the cell cycle and the development of BC.